6 hours ago
Will Semaglutide Prices Drop After 2026 Patent Expirations?
TOPLINE Generic injectable semaglutide could cost as little as $28 per person-year after the initial patent expired in April 2026 — a fraction of current branded prices — and be available in about 162 countries by the end of 2026, covering roughly... Read more.
Owner: Jim TenBroek & Scott Peters through Growth Catalyst Partners & Government Media Executive Group
Owner: John Amato (Publisher & Founder)
Owner: John Palumbo
More from Medscape
Owner: Kohlberg Kravis Roberts (KKR & Co. Inc.) through WebMD (through Medscpae LLC)
Owner: Kohlberg Kravis Roberts (KKR & Co. Inc.) through WebMD (through Medscpae LLC)
Owner: Kohlberg Kravis Roberts (KKR & Co. Inc.) through WebMD (through Medscpae LLC)
Search & Explore
Search the news with more context, not more noise.
Today's Media Watch
Your daily guide to the stories shaping media, journalism, and public trust.
Who Owns the Narrative?
See the impact of media framing through real-world case studies.
The EU-Mercosur
Free-trade agreements divide opinion. The EU-Mercosur deal sparked conflicting headlines, reflecting debates over prices, industry, environment, and self-sufficiency.
COVID Vaccinations
This analysis of COVID vaccination coverage shows how ideology, ownership, and political framing shape media narratives, influencing both what we think and how we think.
Greenland
This case study explores the Greenland acquisition scenario as a real-world media literacy stress test, revealing how ideology, ownership, and political framing shape the stories we consume.
Learn About Our Fact-Based Transparency System
Our proprietary bias labels help you understand each outlet’s political orientation, editorial independence, and credibility based on factors like ownership, funding, affiliations, content, and media freedom. Learn more in the Perspectify FAQ.
Learn more
